Xyra, LLC
5Patents
5Active
5Granted
58Portfolio score
Filing activity: Nov 1, 2022 → Oct 4, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11759640B2 | Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations | Physics | 4 | Active |
| US11975202B2 | Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations | Physics | 1 | Active |
| US12257228B2 | Cardioversion methods using budiodarone | Human Necessities | 0 | Active |
| US11839768B2 | Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations | Physics | 0 | Active |
| US12115373B2 | Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.